Alzheimer’s Predictor Tested in Blood
A recent study conducted in the US has suggested that the presence of high level of fat in the bloodstream may increase the risk of Alzheimer’s disease.
The Neurology journal issued on Wednesday cites a study on a biomarker in the blood that is likely to predict the development of Alzheimer’s over the course of the coming decade.
This particular study tested 99 women aged from 70-79. They were free of dementia when the study started. The researchers were specifically keeping an eye on the level of serum ceramides, a kind of fat element found throughout the body, of these women. During the 9-year span of the study, it has been seen that women with highest level of biomarker are ten times more vulnerable than women who have lowest level of that agent.
The findings of the study strongly suggest that high levels of serum ceramides are likely to increase the risk of Alzheimer’s disease.
On the other hand, the science director of the Alzheimer’s Association, Dr. Bill Thies, hopes high about 3 drugs for Alzheimer’s disease, which are now going through clinical trials.

